90 results
10-K
2023 FY
EX-10.12
ATOS
Atossa Therapeutics Inc
Annual report
1 Apr 24
4:05pm
10-K
2023 FY
EX-10.13
ATOS
Atossa Therapeutics Inc
Annual report
1 Apr 24
4:05pm
10-K
2022 FY
EX-10.3
ATOS
Atossa Therapeutics Inc
Annual report
22 Mar 23
4:10pm
8-K
EX-10.1
ATOS
Atossa Therapeutics Inc
22 Dec 17
Entry into a Material Definitive Agreement
12:00am
8-K
EX-10.2
ATOS
Atossa Therapeutics Inc
22 Dec 17
Entry into a Material Definitive Agreement
12:00am
8-K
EX-10.1
o8e81txg
5 Aug 16
Entry into a Material Definitive Agreement
12:00am
8-K
EX-10.1
xcr ox5hx
27 May 16
Atossa Genetics Announces $10 Million At-the-Market
12:00am
8-K
EX-10.1
jnhiuulh nl
20 May 16
Entry into a Material Definitive Agreement
12:00am
8-K
EX-10.1
3cqi010b3
8 Feb 16
Entry into a Material Definitive Agreement
12:00am
8-K
EX-10.1
yv2marirpuu9a
16 Dec 15
Entry into a Material Definitive Agreement
12:00am
8-K
EX-10.1
kxozwll ep
4 Sep 15
Announces Appointment of Scott Youmans as Chief Operating Officer
12:00am
8-K
EX-10.1
pqmfd25
10 Jun 15
Entry into a Material Definitive Agreement
12:00am
8-K
EX-10.2
kuj0cas7 sddlyd
10 Jun 15
Entry into a Material Definitive Agreement
12:00am
8-K
EX-10.1
6p74q0n4jkqk8smip
28 May 15
Entry into a Material Definitive Agreement
12:00am
8-K
EX-10.1
me9tu
18 May 15
Entry into a Material Definitive Agreement
12:00am